Welcome to our dedicated page for Quipt Home Medical news (Ticker: QIPT), a resource for investors and traders seeking the latest updates and insights on Quipt Home Medical stock.
Quipt Home Medical Corp. (QIPT) generates a steady flow of news as a U.S.-based home medical equipment provider focused on end-to-end respiratory care and in-home chronic disease management. Company press releases regularly discuss its role in providing in-home monitoring and disease management services for patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions in the United States healthcare market.
News coverage for QIPT commonly includes financial results and operational updates. For example, Quipt issues quarterly and annual earnings releases that highlight revenue trends, recurring revenue from equipment rentals and respiratory resupplies, Adjusted EBITDA, and operational metrics such as the number of unique patients served and set-ups or deliveries completed. These releases often include management commentary on business performance, revenue stabilization, and the contribution of acquisitions and partnerships.
Another major category of Quipt news involves strategic transactions. The company has announced acquisitions of durable medical equipment providers and a joint venture interest in Hart Medical Equipment, as well as a preferred provider agreement with Ballad Health. These items describe how Quipt works with health systems and hospitals to integrate home medical equipment and respiratory care into hospital discharge processes and post-acute care coordination.
More recently, Quipt’s news has featured corporate and M&A developments, including activist shareholder commentary and, most notably, the December 2025 announcement of a definitive Arrangement Agreement under which a special purpose acquisition vehicle funded by affiliates of Kingswood Capital Management and Forager Capital Management will acquire all outstanding Quipt shares for cash. This transaction, if completed, is expected to result in Quipt becoming a privately held company and its shares being delisted from The Nasdaq Capital Market and the Toronto Stock Exchange.
Investors and observers using this QIPT news page on Stock Titan can review these earnings announcements, acquisition and joint venture updates, health system partnership news, and transaction-related disclosures in one place, helping them understand how Quipt’s home medical equipment and respiratory care strategy is reflected in its public communications.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Quipt Home Medical Corp. (NASDAQ:QIPT) has signed a significant national insurance contract with a major U.S. health insurer, marking its second such agreement since April 2022. This contract is expected to enhance patient access and accelerate organic growth. The company is currently serving over 270,000 active patients and reports an anticipated annualized revenue of $220 million and adjusted EBITDA of $49 million. CEO Greg Crawford expressed optimism about leveraging this contract to capture more eligible patients and enhance the company's growth strategy, following its largest acquisition to date.
Quipt Home Medical Corp. (NASDAQ: QIPT) announced its participation in the Sidoti March Small-Cap Virtual Conference, scheduled for March 22-23, 2023. Members of the management team will host a webcasted presentation on March 22 at 1:45 PM ET, focusing on their end-to-end respiratory care services and in-home monitoring solutions. This event highlights Quipt's strategy to expand its offerings for chronic disease management in the U.S. healthcare market. The live presentation will be accessible on Quipt's website and available for replay afterward.